Studies have shown that inhibiting N-glycosylation, such as through the use of 2-deoxyglucose (2DG) or a combination of metformin and 2DG, can reduce PD-L1 expression on the surface of breast cancer cells. Here, CD274 is linked to breast carcinoma.